Results: 1-25 | 26-44
Results: 1-25/44

Authors: Lind, K Kresse, M Muller, RH
Citation: K. Lind et al., Evaluation of desorption of proteins adsorbed to hydrophilic surfaces by two-dimensional electrophoresis, PROTEOMICS, 1(9), 2001, pp. 1059-1066

Authors: Muller, RH Kleinsteuber, S Babel, W
Citation: Rh. Muller et al., Physiological and genetic characteristics of two bacterial strains utilizing phenoxypropionate and phenoxyacetate herbicides, MICROBI RES, 156(2), 2001, pp. 121-131

Authors: Krause, KP Muller, RH
Citation: Kp. Krause et Rh. Muller, Production of aqueous shellac dispersions by high pressure homogenisation, INT J PHARM, 223(1-2), 2001, pp. 89-92

Authors: Scholer, N Olbrich, C Tabatt, K Muller, RH Hahn, H Liesenfeld, O
Citation: N. Scholer et al., Surfactant, but not the size of solid lipid nanoparticles (SLN) influencesviability and cytokine production of macrophages, INT J PHARM, 221(1-2), 2001, pp. 57-67

Authors: Jacobs, C Kayser, O Muller, RH
Citation: C. Jacobs et al., Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone, INT J PHARM, 214(1-2), 2001, pp. 3-7

Authors: Lippacher, A Muller, RH Mader, K
Citation: A. Lippacher et al., Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles, INT J PHARM, 214(1-2), 2001, pp. 9-12

Authors: Krause, KP Muller, RH
Citation: Kp. Krause et Rh. Muller, Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation, INT J PHARM, 214(1-2), 2001, pp. 21-24

Authors: Gessner, A Olbrich, C Schroder, W Kayser, O Muller, RH
Citation: A. Gessner et al., The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles, INT J PHARM, 214(1-2), 2001, pp. 87-91

Authors: Demirel, M Yazan, Y Muller, RH Kilic, F Bozan, B
Citation: M. Demirel et al., Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles, J MICROENC, 18(3), 2001, pp. 359-371

Authors: Lind, K Kresse, M Muller, RH
Citation: K. Lind et al., Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo, ELECTROPHOR, 22(16), 2001, pp. 3514-3521

Authors: Muller, RH Jacobs, C Kayser, O
Citation: Rh. Muller et al., Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future, ADV DRUG DE, 47(1), 2001, pp. 3-19

Authors: Hoffmann, D Kleinsteuber, S Muller, RH Babel, W
Citation: D. Hoffmann et al., Development and application of PCR primers for the detection of the tfd genes in Delftia acidovorans P4a involved in the degradation of 2,4-D, ACT BIOTECH, 21(4), 2001, pp. 321-331

Authors: Muller, RH Babel, W
Citation: Rh. Muller et W. Babel, Pseudo-recalcitrance of chlorophenoxyalkanoate herbicides - Correlation tothe availability of alpha-ketoglutarate, ACT BIOTECH, 21(3), 2001, pp. 227-242

Authors: Scholer, N Krause, K Kayser, O Muller, RH Borner, K Hahn, H Liesenfeld, O
Citation: N. Scholer et al., Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis, ANTIM AG CH, 45(6), 2001, pp. 1771-1779

Authors: Wissing, SA Muller, RH
Citation: Sa. Wissing et Rh. Muller, Solid lipid nanoparticles (SLN) - a novel carrier for UV blockers, PHARMAZIE, 56(10), 2001, pp. 783-786

Authors: Rudolph, C Lausier, J Naundorf, S Muller, RH Rosenecker, J
Citation: C. Rudolph et al., In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers, J GENE MED, 2(4), 2000, pp. 269-278

Authors: Peters, K Leitzke, S Diederichs, JE Borner, K Hahn, H Muller, RH Ehlers, S
Citation: K. Peters et al., Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection, J ANTIMICRO, 45(1), 2000, pp. 77-83

Authors: Grau, MJ Kayser, O Muller, RH
Citation: Mj. Grau et al., Nanosuspensions of poorly soluble drugs - reproducibility of small scale production, INT J PHARM, 196(2), 2000, pp. 155-159

Authors: Jacobs, C Kayser, O Muller, RH
Citation: C. Jacobs et al., Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide, INT J PHARM, 196(2), 2000, pp. 161-164

Authors: Krause, KP Kayser, O Mader, K Gust, R Muller, RH
Citation: Kp. Krause et al., Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation, INT J PHARM, 196(2), 2000, pp. 169-172

Authors: Liedtke, S Wissing, S Muller, RH Mader, K
Citation: S. Liedtke et al., Influence of high pressure homogenisation equipment on nanodispersions characteristics, INT J PHARM, 196(2), 2000, pp. 183-185

Authors: Zimmermann, E Muller, RH Mader, K
Citation: E. Zimmermann et al., Influence of different parameters on reconstitution of lyophilized SLN, INT J PHARM, 196(2), 2000, pp. 211-213

Authors: Lippacher, A Muller, RH Mader, K
Citation: A. Lippacher et al., Investigation on the viscoelastic properties of lipid based colloidal drugcarriers, INT J PHARM, 196(2), 2000, pp. 227-230

Authors: Seehof, K Kresse, M Mader, K Muller, RH
Citation: K. Seehof et al., Interactions of nanoparticles with body proteins - improvement of 2D-PAGE-analysis by internal standard, INT J PHARM, 196(2), 2000, pp. 231-234

Authors: Scholer, N Zimmermann, E Katzfey, U Hahn, H Muller, RH Liesenfeld, O
Citation: N. Scholer et al., Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages, INT J PHARM, 196(2), 2000, pp. 235-239
Risultati: 1-25 | 26-44